25 reports

Skin Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Skin Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Skin Cancer pipeline products, Skin

  • Skin Cancer
  • France
  • Germany
  • Italy
  • Market Size
  • PRESCRIPTION SKIN CANCER PREPARATIONS IN DEVELOPMENT
  • 11: Prescription Skin Cancer Drugs
  • Skin Cancer
  • Europe
  • World
  • Market Size
  • Galderma S.A.

Skin Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Skin Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Skin Cancer pipeline products, Skin

  • Skin Cancer
  • Europe
  • France
  • Germany
  • Market Size

Japan Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) Japan Skin Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Pathology
  • Skin Cancer
  • Japan
  • Market Size

UK Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) UK Skin Cancer Epidemiology ##) Marketed Drugs for

  • Cancer
  • Pathology
  • Skin Cancer
  • United Kingdom
  • Market Size

Italy Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) Italy Skin Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Pathology
  • Skin Cancer
  • Italy
  • Market Size

Germany Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) Germany Skin Cancer Epidemiology ##) Marketed Drug

  • Cancer
  • Pathology
  • Skin Cancer
  • Germany
  • Market Size

France Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) France Skin Cancer Epidemiology ##) Marketed Drugs

  • Cancer
  • Pathology
  • Skin Cancer
  • France
  • Market Size

US Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) US Skin Cancer Epidemiology ##) Marketed Drugs for

  • Cancer
  • Pathology
  • Skin Cancer
  • Market Size

Spain Skin Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Skin Cancer Treatments ##) Skin Cancer Pipeline ##) Spain Skin Cancer Epidemiology ##) Marketed Drugs fo

  • Cancer
  • Pathology
  • Skin Cancer
  • Spain
  • Market Size
  • APPENDIX: SKIN CANCER
  • TYPES AND SYMPTOMS OF SKIN CANCER
  • Skin Cancer
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • 2.1 INTRODUCTION TO SKIN CANCER
  • 2.1 INTRODUCTION TO SKIN CANCER
  • Skin Cancer
  • Biopharmaceuticals Inc.
  • Merck & Co., Inc.
  • Navidea Biopharmaceuticals, Inc.
  • SciBase Company

Skin Cancer Vaccine Mechanism ##.

  • Skin Cancer
  • Therapy
  • Vaccine
  • World
  • Forecast
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Skin Cancer Treatment Drugs Sales Volume by Type
  • CHAPTER IV SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Market Size
  • CHAPTER III SKIN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Skin Cancer
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.
  • Nonmelanomatous Skin Cancer Overview
  • Nonmelanomatous Skin Cancer - Discontinued Products
  • Dermatological Condition
  • Skin Cancer
  • Germany
  • World
  • Product Initiative
  • NONMELANOMATOUS SKIN CANCER - DORMANT PROJECTS, H1 2015
  • NONMELANOMATOUS SKIN CANCER - PIPELINE BY ADVANCELL, H1 2015
  • Cancer
  • Pathology
  • Skin Cancer
  • World
  • OCT 01, 2014: VERISANTE TECHNOLOGY ANNOUNCES SUBMISSION TO THE FDA FOR AURA, A SKIN CANCER DETECTION DEVICE
  • MULTISPECTRAL IMAGING (MSI) SYSTEM - PRODUCT DESCRIPTION
  • Skin Cancer
  • Canada
  • United States
  • Company
  • Verisante Technology, Inc.
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER
  • Cancer
  • Skin Cancer
  • United States
  • Product Initiative
  • Novartis AG
  • APR 29, 2016: NICE RECOMMENDS COMBINED DRUG THERAPY PROVEN TO EXTEND LIFE FOR SKIN CANCER
  • FEB 25, 2016: NEW TARGETED THERAPY FOR TREATMENT OF SERIOUS FORM OF SKIN CANCER APPROVED IN CANADA
  • Skin Cancer
  • Targeted Therapy
  • United States
  • Product Initiative
  • Novartis AG
  • Verisante Technology Inc - Company Statement
  • Name
  • Skin Cancer
  • Canada
  • United States
  • Company Financials
  • Verisante Technology, Inc.
  • Clinical Trial profile. 108 Trial Title
  • Therapy Area Indication(s)
  • Cancer
  • Skin Cancer
  • Therapy
  • World
  • Product Initiative
  • NEOPULSE - SKIN CANCER
  • NEOPULSE - SKIN CANCER PRODUCT OVERVIEW
  • Cancer
  • Clinical Trial
  • Ear, Nose, And Throat Medicine
  • Hospital
  • Skin Cancer
  • SKIN CANCER IHC DIAGNOSTIC TEST - PRODUCT STATUS
  • MAGE-A3 SKIN CANCER ASSAY - PRODUCT DESCRIPTION
  • Biomarker
  • Skin Cancer
  • United States
  • Company
  • GlobalData's company